Last updated on August 2019

An Immunotherapy Study of Nivolumab Plus Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer


Find a site near you

Start Over

Local Institution

Stamford, CT United States
  Connect »

Local Institution

Washington, WA United States
  Connect »

Local Institution

Orlando, FL United States
  Connect »

Local Institution

Chicago, IL United States
  Connect »

Local Institution

Boston, MA United States
  Connect »

Local Institution

Hackensack, NJ United States
  Connect »

Local Institution

Buffalo, NY United States
  Connect »

Local Institution

Lake Success, NY United States
  Connect »

Local Institution

West Reading, PA United States
  Connect »

Local Institution

Charleston, SC United States
  Connect »

Local Institution

Ciudad Autonoma de Buenos Aires, Argentina
  Connect »

Local Institution

Mar del Plata, Argentina
  Connect »

Local Institution

Buenos Aires, Argentina
  Connect »

Local Institution

San Juan, Argentina
  Connect »

Local Institution

Santiago de Chile, Chile
  Connect »

Local Institution

Independencia, Chile
  Connect »

Local Institution

Vina del Mar, Chile
  Connect »

Local Institution

Saint Herblain, France
  Connect »

Local Institution

Toulouse Cedex 9, France
  Connect »

Local Institution

Ciudad de Mexico, Mexico
  Connect »

Local Institution

Biala Podlaska, Poland
  Connect »

Local Institution

Saint-Petersburg, Russian Federation
  Connect »

Local Institution

Santiago Compostela, Spain
  Connect »

Local Institution

Rio Cuarto, Argentina
  Connect »

Local Institution

Marseille Cedex 9, France
  Connect »

Local Institution

Cluj-Napoca, Romania
  Connect »

Local Institution

Valenciennes, France
  Connect »

Akh

Vienna, Austria
  Connect »

Chu Angers

Angers Cedex 10, France
  Connect »

Local Institution

Besancon Cedex, France
  Connect »